Collectively, the current study revealed the role of the Meg3/miR-708/SOCS3 axis in determining colonic stemness in early stage CRC, demonstrating that targeting the combination of Meg3 and miR-708 might represent a diagnostic and therapeutic strategy in early stage CRC. The gene discussed is MEG3; the disease is colorectal carcinoma.